Exodus Point Capital Management, LP Nuvation Bio Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$1.68 - $2.5 $43,984 - $65,452
26,181 New
26,181 $50,000
Q2 2021

Aug 16, 2021
SELL
$9.22 - $14.48 $1.47 Million - $2.3 Million
-159,162 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.0 - $14.57 $1.43 Million - $2.32 Million
159,162 New
159,162 $1.66 Million

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email